| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 13 |
| 1 | METHOTREXATE | 12 |
| 2 | LEFLUNOMIDE | 11 |
| 3 | BISOPROLOL FUMARATE | 9 |
| 4 | CIPROFLOXACIN | 9 |
| 5 | CIPROFLOXACIN HYDROCHLORIDE | 9 |
| 6 | CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | 9 |
| 7 | IBUPFROFEN | 9 |
| 8 | IBUPROFEN | 9 |
| 9 | IBUPROFEN 200 MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AURANOFIN | 1 | 0.0049 |
| 1 | METHYLPREDNISOLONE ACETATE | 8 | 0.0010 |
| 2 | FLURBIPROFEN | 1 | 0.0007 |
| 3 | CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | 9 | 0.0004 |
| 4 | BETAMETHASONE VALERATE FOAM | 1 | 0.0002 |
| 5 | LORLATINIB | 1 | 0.0001 |
| 6 | ICOSAPENT ETHYL | 1 | 0.0001 |
| 7 | OXYBUTYNIN CHLORIDE | 1 | 0.0001 |
| 8 | LEFLUNOMIDE | 11 | 0.0001 |
| 9 | DOFETILIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 13 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 2 | Antirheumatic Agent [EPC] | 11 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 9 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 6 | Aminosalicylate [EPC] | 2 |
| 7 | Azole Antifungal [EPC] | 2 |
| 8 | Benzodiazepine [EPC] | 2 |
| 9 | Alkylating Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 11 | 0.0001 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 9 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 12 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 2 | 0.0000 |
| 8 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |